Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTSC
3301
CALL
DELISTED
MTS Systems Corp
MTSC
| $5.25M | ﹤0.01% |
90,200
+62,900
| +230% | +$2.27M |
|
3302
CALL
Agios Pharmaceuticals
AGIO
$1.99B
| $5.24M | ﹤0.01% |
121,000
+39,200
| +48% | +$1.55M |
|
3303
PUT
Green Dot
GDOT
$760M
| $5.24M | ﹤0.01% |
93,900
+72,400
| +337% | +$4.11M |
|
3304
Protolabs
PRLB
$1.91B
| $5.24M | ﹤0.01% |
34,157
+20,338
| +147% | +$2.87M |
|
3305
NeoGenomics
NEO
$2.32B
| $5.23M | ﹤0.01% |
97,145
+77,623
| +398% | +$3.51M |
|
3306
NovaGold Resources
NG
$3.84B
| $5.23M | ﹤0.01% |
540,358
-443,770
| -45% | -$4.69M |
|
|
MGLN
3307
DELISTED
Magellan Health Services, Inc.
MGLN
| $5.22M | ﹤0.01% |
62,997
+48,989
| +350% | +$3.88M |
|
3308
CALL
FormFactor
FORM
$7.94B
| $5.22M | ﹤0.01% |
121,300
+107,500
| +779% | +$3.88M |
|
3309
PUT
Brighthouse Financial
BHF
$3.05B
| $5.21M | ﹤0.01% |
143,900
+57,100
| +66% | +$1.92M |
|
3310
Williams-Sonoma
WSM
$27.7B
| $5.21M | ﹤0.01% |
102,224
-110,152
| -52% | -$5.64M |
|
|
SBNY
3311
DELISTED
Signature Bank
SBNY
| $5.21M | ﹤0.01% |
38,473
+21,530
| +127% | +$2.25M |
|
3312
CALL
AptarGroup
ATR
$8.46B
| $5.2M | ﹤0.01% |
38,000
-4,900
| -11% | -$608K |
|
|
NARI
3313
CALL
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $5.2M | ﹤0.01% |
59,600
+32,000
| +116% | +$2.26M |
|
3314
CALL
Rocket Pharmaceuticals
RCKT
$424M
| $5.2M | ﹤0.01% |
94,800
+83,600
| +746% | +$3.05M |
|
3315
CALL
Kratos Defense & Security Solutions
KTOS
$9.76B
| $5.19M | ﹤0.01% |
189,200
+94,000
| +99% | +$2.06M |
|
|
KSU
3316
DELISTED
Kansas City Southern
KSU
| $5.19M | ﹤0.01% |
25,403
+16,610
| +189% | +$3.12M |
|
3317
HEICO Corp
HEI
$47B
| $5.18M | ﹤0.01% |
39,138
-2,707
| -6% | -$330K |
|
3318
PUT
Silicon Motion
SIMO
$8.33B
| $5.18M | ﹤0.01% |
107,600
+80,600
| +299% | +$3.29M |
|
3319
iShares Morningstar Mid-Cap ETF
IMCB
$1.71B
| $5.18M | ﹤0.01% |
88,420
-388
| -0.4% | -$21.2K |
|
3320
BILL Holdings
BILL
$5.01B
| $5.17M | ﹤0.01% |
+37,904
| New | +$4.47M |
|
3321
CALL
Direxion Daily FTSE China Bull 3X ETF
YINN
$670M
| $5.17M | ﹤0.01% |
12,810
-245
| -2% | -$91.8K |
|
|
QVCGA
3322
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $5.17M | ﹤0.01% |
9,426
+1,150
| +14% | +$518K |
|
3323
PUT
Coeur Mining
CDE
$21.7B
| $5.16M | ﹤0.01% |
499,000
+31,700
| +7% | +$260K |
|
3324
Zions Bancorporation
ZION
$9.89B
| $5.16M | ﹤0.01% |
118,704
+7,472
| +7% | +$276K |
|
3325
Boston Properties
BXP
$11.1B
| $5.16M | ﹤0.01% |
+54,539
| New | +$4.87M |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.